|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DGX | Davis J. E. | CEO and President | Nov 25 '25 | Option Exercise | 95.80 | 55,093 | 5,277,634 | 175,573 | Nov 28 04:30 PM |
| DGX | Davis J. E. | CEO and President | Nov 25 '25 | Sale | 192.22 | 55,093 | 10,589,760 | 120,480 | Nov 28 04:30 PM |
| DGX | Davis J. E. | Officer | Nov 25 '25 | Proposed Sale | 192.22 | 55,093 | 10,589,762 | Nov 25 04:24 PM | |
| DGX | Davis J. E. | CEO and President | Apr 02 '25 | Sale | 168.46 | 39,191 | 6,602,074 | 127,623 | Apr 04 08:29 PM |
| DGX | Davis J. E. | Officer | Apr 02 '25 | Proposed Sale | 170.00 | 39,191 | 6,662,470 | Apr 02 10:20 AM | |
| DGX | Davis J. E. | EVP, General Diagnostics | Mar 16 '20 | Sale | 87.75 | 3,513 | 308,251 | 38,086 | Mar 17 04:37 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Feb 26 '20 | Sale | 111.09 | 510 | 56,656 | 40,392 | Feb 28 05:50 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Feb 27 '20 | Sale | 109.02 | 1,100 | 119,922 | 38,105 | Feb 28 05:50 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Feb 25 '20 | Sale | 112.73 | 598 | 67,413 | 41,454 | Feb 26 04:34 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Jan 02 '20 | Option Exercise | 68.64 | 143,546 | 9,853,318 | 180,080 | Jan 03 04:39 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Jan 02 '20 | Sale | 105.57 | 143,537 | 15,153,864 | 36,543 | Jan 03 04:39 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Apr 24 '19 | Option Exercise | 60.67 | 47,574 | 2,886,552 | 84,108 | Apr 26 04:29 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Apr 24 '19 | Sale | 95.00 | 47,574 | 4,519,530 | 36,534 | Apr 26 04:29 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Apr 08 '19 | Sale | 90.29 | 8,000 | 722,332 | 36,534 | Apr 10 04:30 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Mar 05 '18 | Sale | 101.00 | 5,122 | 517,322 | 37,067 | Mar 06 07:39 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Feb 27 '18 | Sale | 104.10 | 1,150 | 119,715 | 37,671 | Mar 01 04:56 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Feb 28 '18 | Sale | 104.99 | 648 | 68,034 | 37,023 | Mar 01 04:56 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Feb 26 '18 | Sale | 102.74 | 494 | 50,754 | 39,677 | Feb 27 04:37 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Jan 02 '18 | Option Exercise | 52.16 | 63,880 | 3,332,300 | 101,423 | Jan 04 04:34 PM |
| DGX | Davis J. E. | EVP, General Diagnostics | Jan 02 '18 | Sale | 98.67 | 63,880 | 6,303,359 | 38,053 | Jan 04 04:34 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite